|
Name |
4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene
|
| Molecular Formula | C10H16 | |
| IUPAC Name* |
4,7,7-trimethylbicyclo[4.1.0]hept-2-ene
|
|
| SMILES |
CC1CC2C(C2(C)C)C=C1
|
|
| InChI |
InChI=1S/C10H16/c1-7-4-5-8-9(6-7)10(8,2)3/h4-5,7-9H,6H2,1-3H3
|
|
| InChIKey |
LGNSZMLHOYDATP-UHFFFAOYSA-N
|
|
| Synonyms |
4-Carene; 4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene; 29050-33-7; (+)-4-Carene; UNII-PGD00V83F3; (-)-4,7,7-Trimethylbicyclo(4.1.0)hept-2-ene; PGD00V83F3; Bicyclo(4.1.0)hept-2-ene, 4,7,7-trimethyl-, (-)-; CHEBI:89934; DTXSID80871119; DB-009809; DB-071478; DB-071479; FT-0692431; FT-0740960; 4,7,7-Trimethylbicyclo[4.1.0]hept-2-ene #; EN300-188036; Q27162117
|
|
| CAS | 29050-33-7 | |
| PubChem CID | 530422 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 136.23 | ALogp: | 3.3 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 10 | QED Weighted: | 0.446 |
| Caco-2 Permeability: | -4.362 | MDCK Permeability: | 0.00002530 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.049 |
| Blood-Brain-Barrier Penetration (BBB): | 0.899 | Plasma Protein Binding (PPB): | 90.96% |
| Volume Distribution (VD): | 2.11 | Fu: | 12.31% |
| CYP1A2-inhibitor: | 0.524 | CYP1A2-substrate: | 0.706 |
| CYP2C19-inhibitor: | 0.21 | CYP2C19-substrate: | 0.894 |
| CYP2C9-inhibitor: | 0.365 | CYP2C9-substrate: | 0.684 |
| CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.769 |
| CYP3A4-inhibitor: | 0.191 | CYP3A4-substrate: | 0.365 |
| Clearance (CL): | 14.458 | Half-life (T1/2): | 0.146 |
| hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.011 |
| Drug-inuced Liver Injury (DILI): | 0.039 | AMES Toxicity: | 0.005 |
| Rat Oral Acute Toxicity: | 0.068 | Maximum Recommended Daily Dose: | 0.04 |
| Skin Sensitization: | 0.045 | Carcinogencity: | 0.039 |
| Eye Corrosion: | 0.926 | Eye Irritation: | 0.958 |
| Respiratory Toxicity: | 0.279 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001145 | ![]() |
0.286 | D0V8HA | ![]() |
0.204 | ||
| ENC000574 | ![]() |
0.286 | D04CSZ | ![]() |
0.191 | ||
| ENC000153 | ![]() |
0.286 | D05VQI | ![]() |
0.188 | ||
| ENC002652 | ![]() |
0.283 | D0K7LU | ![]() |
0.188 | ||
| ENC001166 | ![]() |
0.280 | D0F1UL | ![]() |
0.182 | ||
| ENC001898 | ![]() |
0.273 | D0P0HT | ![]() |
0.179 | ||
| ENC002228 | ![]() |
0.267 | D0D2TN | ![]() |
0.176 | ||
| ENC000790 | ![]() |
0.267 | D08PIQ | ![]() |
0.176 | ||
| ENC001834 | ![]() |
0.259 | D0CZ1Q | ![]() |
0.176 | ||
| ENC001321 | ![]() |
0.259 | D0I5DS | ![]() |
0.176 | ||